AC
ALXN

Allstate Corporation’s Alexion Pharmaceuticals ALXN Stock Holding History

Allstate Corporation’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,319
Closed -$426K – 730
2021
Q2 		$426K Hold
2,319
– – 0.01% 565
2021
Q1 		$355K Buy
2,319
+422
+22% +$65.3K 0.01% 629
2020
Q4 		$296K Buy
1,897
+87
+5% +$11.2K 0.01% 624
2020
Q3 		$207K Sell
1,810
-3,801
-68% -$410K 0.01% 647
2020
Q2 		$630K Buy
+5,611
New +$596K 0.02% 367
2019
Q4 		– Sell
-3,662
Closed -$359K – 655
2019
Q3 		$359K Sell
3,662
-5,640
-61% -$636K 0.01% 454
2019
Q2 		$1.22M Buy
9,302
+377
+4% +$48.6K 0.02% 371
2019
Q1 		$1.21M Buy
8,925
+6,249
+234% +$777K 0.03% 285
2018
Q4 		$261K Buy
+2,676
New +$316K 0.01% 366
2017
Q2 		– Sell
-14,957
Closed -$1.81M – 320
2017
Q1 		$1.81M Sell
14,957
-26,213
-64% -$3.38M 0.11% 129
2016
Q4 		$5.04M Buy
+41,170
New +$5.04M 0.3% 104

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Allstate Corporation's ALXN Position: Q3 2021 in Review

Allstate Corporation sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 2,319 shares — an estimated $426K sold.

Allstate Corporation first reported a position in ALXN in Q4 2016 and held it in 11 quarters. The position peaked at $5.04M in Q4 2016. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Allstate Corporation reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Allstate Corporation sold 2,319 Alexion Pharmaceuticals shares in Q3 2021, an estimated $426K.
  • Allstate Corporation first reported a position in Alexion Pharmaceuticals in Q4 2016 and held it in 11 quarters.
  • Allstate Corporation's Alexion Pharmaceuticals position peaked at $5.04M in Q4 2016.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Allstate Corporation's 13F filing for Q3 2021, filed 15 Nov 2021.